LyondellBasell Closes SJS Plastiblends Buy

LyondellBasell has completed the acquisition of SJS Plastiblends, a polypropylene compounder based at Aurangabad, Maharashtra, India. The Rotterdam-headquartered petrochemicals and plastics giant managed from Texas said the buy paves the way for expansion into India’s growing automotive market.

The deal was announced in August of this year.

"This acquisition underscores our strategy of investing in growth projects that provide a competitive advantage in targeted markets and a strong return on assets," said LyondellBasell CEO Bhavesh (Bob) Patel.

The Aurangabad compounding plant has an annual capacity of around 12,000 t/y. Alongside its existing product lines, in future it will produce LyondellBasell's Hostacom glass fiber-reinforced, mineral filled and unfilled colored grades as well as its Hifax high impact thermoplastic olefins.

LyondellBasell claims to be the world's largest producer of PP compounds with an annual capacity of 1.2 million t/y. The company has supplied the Indian market – one of the world’s fastest growing – through imports and tolling arrangements since 2009.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.